iVeena: Funding, Investors & Team (Sep 2026)
iVeena has developed five products that are in the advanced stages of preclinical testing and research. These products are aimed at treating various eye conditions such as inflammation after cataract surgery, macular degeneration (Wet AMD), diabetic retinopathy, and glaucoma. The company, founded in 2006 by Bala Ambati, is located in Salt Lake City, Utah.
iVeena has raised $3.0M across 1 funding round on record, the most recent a Series B of $3.0M announced in Feb 2025.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
iVeena Company Profile and Key Stats
Latest funding round on record: Feb 2025.
iVeena Funding Rounds
iVeena Founders and Leadership Team
No contact details are on record for this team yet.
iVeena Funding Compared to Other Biotechnology Startups
iVeena's latest round of $3.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like iVeena in Biotechnology and Salt Lake City
Companies Similar to iVeena
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
iVeena Funding FAQs
What does iVeena do?
iVeena has developed five products that are in the advanced stages of preclinical testing and research. These products are aimed at treating various eye conditions such as inflammation after cataract surgery, macular degeneration (Wet AMD), diabetic retinopathy, and glaucoma. The company, founded in 2006 by Bala Ambati, is located in Salt Lake City, Utah.
How much funding has iVeena raised?
iVeena has raised $3.0M across 1 round on record. The most recent is a Series B of $3.0M announced in Feb 2025.
When did iVeena last raise funding?
iVeena's most recent funding round on record is a Series B of $3.0M, announced in Feb 2025.
Who founded iVeena?
FundedIQ lists Bala Ambati (Founder) at iVeena.
Where is iVeena headquartered?
iVeena is based in Salt Lake City, Utah, United States.
How many employees does iVeena have?
iVeena is in the 1-10 employee band.
How does iVeena's funding compare to other Biotechnology startups?
iVeena's latest round of $3.0M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's iVeena Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for iVeena is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.